Tag: ACC 2016


PCI Appears Safe In Surgically Ineligible Patients: ACC.2016 Study

Abiomed poster April 3 - Devraj Sukul, MD #1A large study at a diverse array of hospitals found that PCI appeared to be safe in patients who were said to be ineligible for surgery.Devraj Sukul, MD, of the University of Michigan Health System in Ann Arbor, presented the results in a moderated poster session at ACC.16 on April 3 Chicago. The poster is titled “The Safety of Percutaneous Coronary Intervention in Patients Turned Down for Surgical Revascularization: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.”The trial examined 99,370 patients who underwent PCI between January 2010 and December 2014 at 33 PCI-capable hospitals in Michigan that had on-site cardiac surgery. Patients were excluded if they had STEMI, cardiac arrest, salvage PCI or prior bypass surgery. Continue readingPCI Appears Safe In Surgically Ineligible Patients: ACC.2016 Study

Impella Buys Time for Complex Procedures: ACC.2016 Live Case

Barnes Jewish #1A live case transmission presented at the American College of Cardiology 2016 Scientific Session on April 3 turned into a lesson on patience, as well as the necessity for hemodynamic support.Broadcasting from Barnes-Jewish Hospital in St. Louis, John M. Lasala, MD, and Jasvindar Singh, MD, tackled the case of an 84-year-old man with severe multivessel disease featuring a 90% calcified mid RCA and 80% tandem calcified proximal and mid LAD stenoses. Continue readingImpella Buys Time for Complex Procedures: ACC.2016 Live Case

Total Revascularization of High Risk Complex 68-year old Patient: ACC.16 Live Case Wrap-Up

Uwash Live Case #1William L. Lombardi, MD, Mark Reisman, MD, Ravi Hira, MD, and Robert Riley, MD, of the University of Washington Medical Center in Seattle presented a live case at ACC.16 on April 2 in which they performed a Protected PCI with Impella on a high-risk patient.The team performed the procedure on a 68-year-old man who was referred for complete percutaneous revascularization and had a history of coronary artery disease and moderate to severe chronic obstructive pulmonary disease. Continue readingTotal Revascularization of High Risk Complex 68-year old Patient: ACC.16 Live Case Wrap-Up

CTO PCIs Safe and Successful, Study Shows: ACC. 16

Poster 148 #2Trying again after a failed chronic total occlusion (CTO) percutaneous coronary intervention (PCI) did not significantly impact the success or safety of subsequent CTO-PCI procedures, according to a study presented at the American College of Cardiology 2016 Scientific Sessions in Chicago.Reporting on an analysis of 1,213 patients who underwent CTO-PCI procedures between 2012 and 2015 at 12 U.S. centers, Aya J. Alame, BA, and Judit Karacsonyi, MD, said that technical and procedural success rates were similar in the two groups of patients that they and her colleagues from the VA North Texas Healthcare System and UT Southwestern Medical Center (Dallas) and from the University of Szeged (Hungary) focused on for this study. Continue readingCTO PCIs Safe and Successful, Study Shows: ACC. 16

Technical Success of CTO-PCI Not Impacted by Age. ACC. 16

Poster 144 #1Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) procedures achieved high technical success rates among all age groups examined in a multicenter U.S. registry study of more than 1,000 cases; however, the oldest patients (≥75 years) were more likely than the younger patients to suffer major adverse cardiac events (MACE). The study results were presented April 2 at the American College of Cardiology Scientific Sessions in Chicago.Rahel Iwnetu, MD, and colleagues at the VA North Texas Healthcare System in Dallas studied clinical, angiographic and outcomes data of 1,216 CTO-PCI procedures performed in 1,195 patients whom they grouped by age (<65, 65-74 and ≥75 years). Continue readingTechnical Success of CTO-PCI Not Impacted by Age. ACC. 16

More Complications with Retrograde vs. Antegrade-Only CTO-PCI. ACC. 16

Poster 134 #2Using the retrograde approach in chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is associated with lower success and higher major adverse cardiovascular event (MACE) rates compared with an antegrade-only approach, according to study results presented at the American College of Cardiology 2016 Scientific Sessions.“The retrograde approach is integral to the hybrid algorithm for CTO PCI,” said abstract presenter Aris Karatasakis, MD, of the University of Texas Southwestern and VA North Texas Healthcare System in Dallas. “It is essential for achieving high success rates; however, it must be used judiciously due to higher potential for complications.” Continue readingMore Complications with Retrograde vs. Antegrade-Only CTO-PCI. ACC. 16

Comorbidities, Complexity Need Not Keep Patients From Getting Needed PCI. ACC 2016

Focusing on reducing inappropriate use of interventional procedures may be doing a disservice to patients who may be helped by revascularization, according to a presentation at the American College of Cardiology 2016 Scientific Session.”Lost in this overemphasis of reducing inappropriate cases also is this issue of patients who ought to come to the cath lab never making it there at all,” said Ajay J. Kirtane, MD, SM, of NewYork-Presbyterian Hospital/Columbia University Medical Center in New York City. Continue readingComorbidities, Complexity Need Not Keep Patients From Getting Needed PCI. ACC 2016

CHIP: As Access to High-Risk Care Expands, Patient Population Grows More Diverse

ACC CHIP Blog Image 2The day before ACC.16 officially kicked off at McCormick Place Chicago, interventionalists and other stakeholders gathered for The Interventional Toolbox for Complex Higher-Risk (and Indicated) Patients (CHIP) event, sponsored by the Cardiovascular Research Foundation.Jeffrey W. Moses, MD, of NewYork-Presbyterian Hospital/Columbia University Medical Center in New York City, detailed the changes happening in patient demographics and benefits of hemodynamic support for high-risk patients undergoing PCI.  Noting that the population is aging, Dr. Moses acknowledged the fragility of patients who are not suitable for surgery. Continue readingCHIP: As Access to High-Risk Care Expands, Patient Population Grows More Diverse

Abiomed and the Mobile Learning Lab will be at ACC 2016 in Chicago

In an effort to continue to provide ongoing and current industry meeting updates and modeled off of last fall’s TCT 2015 blog and social media coverage, the ProtectedPCI.com team will be providing real-time updates during this weekend’s ACC 2016 Scientific Sessions. Dr. Seth Bilazarian of Abiomed will also be providing video recaps of the conference presentations and news … Continue reading “Abiomed and the Mobile Learning Lab will be at ACC 2016 in Chicago”